Mood-Dependent Fluctuations in the Severity of Tardive Dyskinesia and Psoriasis Vulgaris in a Patient with Schizoaffective Disorder: Possible Role of Melatonin

References

• Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton-Tay F. Melatonin: effects on brain function. Advances in Biochemical Psychopharmacology 1974; 11: 315–324
   PubMedGoogle Scholar
• Anton-Tay F., Diaz J. L., Ferandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Barbeau A. Role of peptides in the pathogenesis and treatment of Parkinson's disease. Central Nervous system effects of hypothalamic hormones and other peptides, R. Collu. Raven Press, New York 1979; 403–414
   Google Scholar
• Birau N., Schloot W. Pathological nyctohumeral rhythm of melatonin secretion in psoriasis. IRCS Medical Science 1979; 7: 400
   Google Scholar
• Brown R., Kocsis J. H., Caroff S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Carter R. J., Shuster S. Melanocyte-stimulating hormone-mimetic action of the phenothiazines. Journal of Pharmacy and Pharmacology 1977; 30: 233–235
   Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movements induced by L-dopa in mice. Science 1971; 172: 450–452
   Google Scholar
• Curzon G., Green A. R. Effect of hydrocortisone on rat brain 5-hydroxytryptamine. Life Sciences 1968; 7: 657–661
   PubMed Web of Science ®Google Scholar
• Cutler N., Post R., Rey A., Bunney W. Depression-dependent dyskinesias in two cases of manic depressive illness. New England Journal of Medicine 1981; 304: 1088–1089
   PubMed Web of Science ®Google Scholar
• Diaz B., Blaztquez E. Effect of pinealectomy on plasma glucose, insulin and glucagon levels in the rat. Hormones and Metabolic Research 1986; 18: 225–231
   PubMed Web of Science ®Google Scholar
• Eberle A. N. The melanoctropins: chemistry physiology and mechanisms of action. Karger, Basel 1988; 173–209
   Google Scholar
• Ehrensing R. H., Kastin A. J., Larsons P. F., Bishop G. A. Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia. Diseases of the Nervous System 1977; 38: 303–307
   PubMedGoogle Scholar
• Fibiger H. C., Llyod K. G. Neurobiological substrates of tardive dyskineqia. the GABA hypothesis. Trends in Neurosciences 1984; 7: 462–464
   Web of Science ®Google Scholar
• Fischer P. A., Schneider E., Jacobi P., Maxion H. Effect of Melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrome. European Neurology 1974; 12: 360–368
   PubMed Web of Science ®Google Scholar
• Galdi J., Rieder R. O., Silber D., Bonato R. B. Genetic factors in the response to neuroleptics in schizophrenia: A psychopharniacogenetic study. Psychological Medicine 1981; 11: 713–728
   PubMed Web of Science ®Google Scholar
• Gerner R., Post R., Bunney W. A dopaminergic mechanism of mania. American Journal of Psychiatry 1976; 133: 1177–1180
   PubMedGoogle Scholar
• Jacquet Y. ‘Dystonia’-like postural asymmetry after microinjection of ACTH N-terminal fragments but not after ACTHI-39 in rat brainstem suggests role of neuropeptide mutation in genetic movement disorder. Brain Research 1984; 294: 144–147
   PubMed Web of Science ®Google Scholar
• Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorder after unilateral microinjection of adrenocorticotropin 1–24 in rat brainstem. Science 1982; 218: 175–177
   PubMed Web of Science ®Google Scholar
• Jeste D. V., Wyatt R. J. Dogma disputed: Is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity. Journal of Clinical Psychiatry 1981; 42: 455–451
   PubMed Web of Science ®Google Scholar
• Jeste D. V., Doongaji D. R., Linnoila M. Elevated cerebrospinal fluid noradrenahne in tardive syskinesia. Brirish Journal of Psychiatry 1984; 144: 177–180
   PubMed Web of Science ®Google Scholar
• Kane J. M., Woerner M., Lieberman J. Tardive dyskinesia: Prevalence. incidence, and risk factors. Journal of Clinical Psychopharmacology 1988; 8: 52S–56S, (suppl)
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Redding T. W., Schally A. V. MSH activity in rat pituitaries after pinealectomy. Proceedings of the Society for Experimental Biology and Medicine 1967; 124: 1275–1277
   PubMed Web of Science ®Google Scholar
• Klawans H. L. The pharmacology of tardive dyskinesia. American Journal of Psyhiatry. 1973; 130: 82–86
   PubMedGoogle Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin receptors in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Kozell L., Sandyk K., Wagner G. C., Fisher H. The effects of L-tryptophan on haloperidol induced movement disorder in the rat. Life Sciences 1987; 41: 1739–1744
   PubMed Web of Science ®Google Scholar
• Lal K. P., Saxena S., Mohan D. Tardive dystonia alternating with mania. Biological Psychiatry 1988; 23: 312–316
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Kern H. A. Effects of light on human melatonin production and the human circadian system. Progress in Neuropsychopharmacology and Biological Psychiatry 1983; 7: 551–556
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Nurnberger J. I., Wehr T. A., Pack D., Becker L. E., Powell R. L., Newsome D. A. Supersensitivity to light: possible trait marker for manic-depressive illness. Americuri Journal of Psychiatry 1985; 142: 725–727
   PubMed Web of Science ®Google Scholar
• Lozovsky D., Saller C. F., Kopin I. J. Dopamine receptor binding is increased in diabetic rats. Scimce 1981; 214: 1031–1033
   PubMed Web of Science ®Google Scholar
• Miles A., Philbrick D. R. S. Melatonin and Psychiatry. Biological Psychiatry 1988; 23: 405–425
   PubMed Web of Science ®Google Scholar
• Mukherjee S., Bilder R. M., Sackheim H. A. Tardive dyskinesia and glucose metabolism. Archives of General Psychiatrly 1986; 43: 193
   Web of Science ®Google Scholar
• Mukherjee S., Rosen A. M., Caracci G., Shukla S. Persistent tardive dyskinesia in bipolar patients. Archives of General Psychiatry 1986; 43: 342–346
   PubMed Web of Science ®Google Scholar
• Oxenkrug G. F., McIntyre I. M., Gershon S. Effects of pinealectomy and aging on the serum corticosterone circadian rhythm in rats. Journal of Pineal Research 1984; I: 181–185
   Google Scholar
• Post R. M., Jimerson D. C., Bunney W. E., Goodwin F. K. Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology 1980; 67: 297–305
   PubMed Web of Science ®Google Scholar
• Post R. M., Lake C. R., Jimersson D. C., Bunney W. E., Wood J. H., Ziegler M. G., Goodwin F. K. Cerebrospinal fluid norepinephrine in affective illness. American Journal of Psychiatry 1978; 135: 907–912
   PubMed Web of Science ®Google Scholar
• Rosenthal N. E., Sack D. A., Jacobson F. M., James S. P., Parry B. L., Arendt J., Tamarkin L., Wehr T. A. Melatonin in seasonal affective disorder and phototherapy. Journul of Neural Transmission 1986; 21(suppl): 257–268
   Google Scholar
• Rush M., Diamond F., Alpert M. Depression as a risk factor in tardive dyskinesia. Biological Psychiatry 1982; 17: 387–392
   PubMed Web of Science ®Google Scholar
• Sack R. L., Lewy A. J. Desmethylimipramine treatment increases melatonin producitn in humans. Biological Psychiatry 1986; 21: 406–410
   PubMed Web of Science ®Google Scholar
• Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M., Singer C. M. Human melatonin production decreases with age. Journal of Pineal Research 1986; 3: 379–388
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. The protective function of the pineal gland in tardive dyskinesia. International Journal of Neuroscience 1988; 43: 215–218
   PubMed Web of Science ®Google Scholar
• Sandyk R., Consroe P. F., Lacono R. P. L-tryptophan in drug-induced movement disorders with insomnia. New England Journal of Medicine 1986; 3: 314–1257
   Google Scholar
• Sandyk R., Fisher H. Increased incidence and severity of neuroleptic-induced movement disorder in pinealestomized rats. International Journal of Neuroscience 1989; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Mukherjee S. Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system. International Journal of Neuroscience 1989; 48: 297–301
   PubMed Web of Science ®Google Scholar
• Sandyk R. Hyperglycemia augments the development of neuroleptic-induced perioral movements in the rat. International Journal of Neuroscience., (in press)
   Google Scholar
• Sandyk R., Pardeshi R., Mukherjee S. Melanocyte-stimulating hormone (MSH) and tardive dyskinesia. Society of Biological Psychiatry Annual Meeting, San Francisco, 1989, 1988
   Google Scholar
• Shuster S., Burton J. L., Thody A. J., Goolamali S. K., Burton J. L., Plummer N., Bates D. Melanocyte-stimulating hormone and Parkinsonism. Lancer 1973; 1: 463–465
   PubMed Web of Science ®Google Scholar
• Silverstone T. Dopamine in manic depressive illness: A Pharmacological synthesis. Journal of Affective Disorder 1985; 8: 225–231
   PubMed Web of Science ®Google Scholar
• Souetre E., Salvati E., Belugou J. L., Robert P., Brunet G., Darcourt G. Antidepressant effect of 5-methoxypsoralen: A preliminary report. Psychopharmacology 1988; 95: 430–431
   PubMed Web of Science ®Google Scholar
• Souetre E., Salvat E., Pringuey D., Brunet G., Savelli M., Krebs B., Darcourt G. Rythme circadian de la melatonine dans la depression: Etude transversale et longitudinale. Actual Psychiatriques 1986; 5: 88–93
   Google Scholar
• Terman M., Terman J. S., Quitkin F. M., Cooper T. B., Lo E. S., Gorman J. M., Stewart J. W., McGrath P. J. R Esponse of the melatonin cycle to phototherapy for seasonal affectie disorder. Journal of Neural Transmission 1988; 72: 147–165
   PubMed Web of Science ®Google Scholar
• Wehr T. A., Goodwin F. K. Desynchronization of circadian rhythms as possible sourse of manic-depressive cycles. Psychopharmacology Bulletin 1980; 16: 19–20
   Google Scholar
• Weiner W., Werner I. Mania induced remission of tardive dyskinesia in manic-depressive illness. Annals of Neurology 1982; 12: 229–230
   PubMed Web of Science ®Google Scholar
• Wendel O. T., Waterbury L. D., Pearce L. A. Increase in monoamine concentrations in rat brian following melatonin administration. Experientia 1974; 30: 1167–1168
   PubMedGoogle Scholar
• Wetterberg L., Beck-Friis J., Aperia B. Melatonin cortisol ratio in depression. Lancet 1979; 4: 1361
   Google Scholar
• Willner P. Dopamine and depression: A review of recent evidence. Brain Research Reviews 1933; 287: 211–218
   Google Scholar
• Wolf M. E., Almy G., Toll M., Mosnaim A. D. Mania associated with the use of baclofen. Biological Psychiatry 1982; 17: 751–759
   Google Scholar
• Yassa R., Ghadirian A. M., Schwartz G. Prevalence of tardive dyskinesia in affective disorder patients. Journal of Clinical Psychiatry 1983; 44: 410–412
   PubMedGoogle Scholar